The role of regenerative therapy in the treatment of right ventricular failure: a literature review
Open Access
- 25 November 2020
- journal article
- review article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 11 (1) , 1-9
Abstract
Right ventricular (RV) failure is a commonly encountered problem in patients with congenital heart disease but can also be a consequence of left ventricular disease, primary pulmonary hypertension, or RV-specific cardiomyopathies. Improved survival of the aforementioned pathologies has led to increasing numbers of patients suffering from RV dysfunction, making it a key contributor to morbidity and mortality in this population. Currently available therapies for heart failure were developed for the left ventricle (LV), and there is clear evidence that LV-specific strategies are insufficient or inadequate for the RV. New therapeutic strategies are needed to address this growing clinical problem, and stem cells show significant promise. However, to properly evaluate the prospects of a potential stem cell-based therapy for RV failure, one needs to understand the unique pathophysiology of RV dysfunction and carefully consider available data from animal models and human clinical trials. In this review, we provide a comprehensive overview of the molecular mechanisms involved in RV failure such as hypertrophy, fibrosis, inflammation, changes in energy metabolism, calcium handling, decreasing RV contractility, and apoptosis. We also summarize the available preclinical and clinical experience with RV-specific stem cell therapies, covering the broad spectrum of stem cell sources used to date. We describe two different scientific rationales for stem cell transplantation, one of which seeks to add contractile units to the failing myocardium, while the other aims to augment endogenous repair mechanisms and/or attenuate harmful remodeling. We emphasize the limitations and challenges of regenerative strategies, but also highlight the characteristics of the failing RV myocardium that make it a promising target for stem cell therapy.Keywords
This publication has 67 references indexed in Scilit:
- Forecasting the Impact of Heart Failure in the United StatesCirculation: Heart Failure, 2013
- Right Ventricular Failure and Pathobiology in Patients with Congenital Heart Disease – Implications for Long-Term Follow-UpFrontiers in Pediatrics, 2013
- Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured heartsNature, 2012
- Direct Comparison of Different Stem Cell Types and Subpopulations Reveals Superior Paracrine Potency and Myocardial Repair Efficacy With Cardiosphere-Derived CellsJACC, 2012
- Molecular Signature of a Right Heart Failure Program in Chronic Severe Pulmonary HypertensionAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- A regenerative strategy for heart failure in hypoplastic left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cellsThe Journal of Heart and Lung Transplantation, 2010
- Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted MiceCirculation Research, 2010
- Human Cord Blood Stem Cells Enhance Neonatal Right Ventricular Function in an Ovine Model of Right Ventricular TrainingThe Annals of Thoracic Surgery, 2010
- Intracoronary administration of autologous bone marrow‐derived progenitor cells in a critically ill two‐yr‐old child with dilated cardiomyopathyPediatric Transplantation, 2009
- A Novel Monoclonal Antibody (STRO-3) Identifies an Isoform of Tissue Nonspecific Alkaline Phosphatase Expressed by Multipotent Bone Marrow Stromal Stem CellsStem Cells and Development, 2007